gs3-03: "genomic analysis of 733 her2 breast cancers identifies recurrent pathways alterations..."
Published 1 year ago • 20 plays • Length 12:44Download video MP4
Download video MP3
Similar videos
-
8:15
gs3-02. updated overall survival (os) results from the phase 3 phoebe trial
-
15:26
gs3-04: discussant
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
15:18
gs3-07: "circulating tumor dna (ctdna) dynamics in patients with hormone receptor positive..."
-
35:20
natalie marshall | 2017 san antonio breast cancer symposium
-
1:56
clinical and genomic landscape of breast cancers carrying ccne1 amplification
-
15:53
gs3 -05: "fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection..."
-
15:52
gs3-01: "trastuzumab deruxtecan vs trastuzumab emtansine in patients with her2 metastatic..."
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
0:44
sk-br3 transfection kit
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
0:45
bend-3 transfection reagent
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
1:12
trastuzumab deruxtecan in metastatic her2 breast cancer
-
26:59
dr. david rimm | san antonio breast cancer symposium 2022 | general session
-
1:31
dr. geyer on the rationale for the katherine trial in her2-positive breast cancer
-
2:33
future impact of tailorx on breast cancer management